62 results
Page 2 of 4
8-K
EX-99.1
j3u521m9 2rblp6hd
8 Aug 22
Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones
4:32pm
8-K
jbcrh0e4ah5atd9nnr1
26 Jul 22
Other Events
4:02pm
8-K
EX-99.1
zuj6t7a uep
9 May 22
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
4:31pm
8-K
EX-99.1
n7snp2
28 Feb 22
Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones
4:36pm
8-K
vra9mj
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.1
f49muq4jh8rwqex a7r
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.1
r6x5rb0pn9j w888
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
8-K
l9rs6fzrfni478al06
30 Sep 21
Other Events
7:00am
8-K
EX-99.1
j4jale5jdt4ek9r7o1
9 Aug 21
Business Highlights and Anticipated Second Half 2021 Milestones
7:01am
8-K
EX-99.1
w8i3sk6mtsrjnr3ql5
19 May 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
s46qsjpvmah12n5
7 May 21
Business Highlights and 2021 Anticipated Milestones
7:00am
8-K
gxfq7b4blpbfu541
15 Apr 21
Other Events
7:00am
8-K
EX-99.1
gcgbpgeg8m9
18 Mar 21
Sutro Biopharma Reports Full Year 2020 Financial Results
7:00am